Univest
Univest
  • Markets

Laurus Labs (LAURUSLABS) 52 Week High Streak: Second Straight Session at Rs 2,207.00

  • September 15, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Laurus Labs 52 Week High Streak
Laurus Labs Ltd. (LAURUSLABS) share price reached a fresh 52-week high of Rs 2,207 today and later stood at Rs 2,174, down 0.5% from the previous close. Market cap was Rs 1,15,616.01 crore.

Laurus Labs Ltd. has now set a fresh 52-week high for its second straight session, extending the Laurus Labs 52 Week High Streak that began on 28 October 2026. The stock touched Rs 2,207.00 on 29 October 2026 and last traded at Rs 2,174.00 as of 12:37 PM IST, with a cumulative change of 1.60% across the streak. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established for the continued move.

The previous close was Rs 2,184.95, the day open was Rs 2,190.00 and the day low was Rs 2,172.15, while market capitalisation stands at Rs 1,15,616.01 crore. A repeated fresh 52-week high tells a reader more than a single-day breakout, because the stock has reached a new one-year peak on each of two sessions rather than once. The sections below test that pattern against valuation, sector and peer figures.

Table of Contents

Toggle
  • Laurus Labs 52 Week High Streak: Consecutive High Analysis
  • What the Repeated 52-Week Highs Show
  • Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis
  • Sector and Industry Context
  • Peer Comparison
  • Why Investors Are Watching Laurus Labs
  • About Laurus Labs
  • Frequently Asked Questions
    • How many sessions has Laurus Labs set a fresh 52-week high?
    • What is the Laurus Labs share price today?
    • What is the cumulative change across the Laurus Labs streak?
    • Is a company-specific catalyst confirmed for the repeated highs?
    • What is the market cap of Laurus Labs?
    • What are the P/E and P/B ratios of Laurus Labs?
    • What are the ROE and ROCE of Laurus Labs?
    • What are the EPS, book value and dividend yield of Laurus Labs?
  • Track Laurus Labs Share Price on Univest

Laurus Labs 52 Week High Streak: Consecutive High Analysis

Metric Value
Current Price Rs 2,174
Previous Close Rs 2,184.95
Today's Move Rs -10.95 (-0.5%)
Open Rs 2,190
High Rs 2,207
Low Rs 2,172.15
Market Capitalisation Rs 1,15,616.01 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 2,174 versus the previous close of Rs 2,184.95, a fall of 0.5%. The stock opened at Rs 2,190, reached a high of Rs 2,207 and touched a low of Rs 2,172.15.

Laurus Labs last traded at Rs 2,174.00 as of 29 October 2026 at 12:37 PM IST, down Rs 10.95 or 0.50% from the previous close of Rs 2,184.95. The stock touched a fresh 52-week high of Rs 2,207.00 during the session, its second straight session at a new one-year peak.

The session opened at Rs 2,190.00 and the day low stood at Rs 2,172.15, so the stock moved between Rs 2,172.15 and Rs 2,207.00, a spread of Rs 34.85. The latest traded price of Rs 2,174.00 sits Rs 1.85 above the day low and Rs 33.00 below the day high, which places it near the bottom of the day’s range even though the day’s high is a fresh yearly peak.

Market capitalisation is Rs 1,15,616.01 crore, a measure of company size and not a verdict on quality. The day’s decline and the new 52-week high are two separate facts, and both are shown here exactly as reported, with no cause attached to either.

What the Repeated 52-Week Highs Show

The repeated highs show that Laurus Labs has traded at a new one-year peak on 28 October 2026 and again on 29 October 2026. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established, so the pattern describes what the price did and does not explain why.

A single fresh high records one breakout. Two in a row record that the one-year peak was raised again on the second session, and the latest level is Rs 2,207.00. For readers following Stocks Hitting 52 Week Highs, the useful questions are what that peak sits against and what could change it.

The latest peak is Rs 2,207.00, the day open is Rs 2,190.00 and the previous close is Rs 2,184.95, so the recent range is visible in three figures. Whether the streak extends to a third straight session is a question for the next trading day, and no outcome is implied. The valuation sections that follow show where the multiples sit once this move is included.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric Value
Market Capitalisation Rs 1,15,616.01 crore
P/E Ratio 107.97x
P/B Ratio 20.94x
ROE 18.31%
ROCE 18.2%
EPS Rs 20.24
Book Value Per Share Rs 104.37
Dividend Yield 0.09%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 107.97x, P/B 20.94x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 1,15,616.01 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 107.97x, P/B at 20.94x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.53x, median ROE of 11.22%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric Value
Sector Healthcare
Industry Pharmaceuticals & Drugs
Benchmark Scope same industry
Company P/E Ratio 107.97x
Benchmark Median P/E 31.53x
Benchmark Average P/E 45.86x
Benchmark P/E Range 3.21x to 598.47x
Company P/B Ratio 20.94x
Benchmark Median P/B 2.74x
Company ROE 18.31%
Benchmark Median ROE 11.22%
Company ROCE 18.2%
Benchmark Median ROCE 13.1%
Company Market Capitalisation Rs 1,15,616.01 crore
Benchmark Median Market Cap Rs 711.9 crore

Laurus Labs Ltd. (LAURUSLABS) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 107.97x, which is above the benchmark median of 31.53x, a difference of +242.44%. On its own, the P/E gap is a valuation reference point, not a trading call.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.22%, a difference of +63.19%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.1%, a difference of +38.93%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Zydus Lifesciences Ltd. ZYDUSLIFE 1,16,408.7 25.9 4.34 19.69 21.39
Cipla Ltd. CIPLA 1,09,062.53 37.93 3.1 11.83 16
Dr. Reddy's Laboratories Ltd. DRREDDY 1,08,925.78 39.81 2.87 11.69 13.75
Mankind Pharma Ltd. MANKIND 1,03,286.06 45.74 5.83 12.69 13.24
Aurobindo Pharma Ltd. AUROPHARMA 93,959.21 25.42 2.42 9.93 12.76

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 107.97x compared with the displayed peer median of 37.93x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 18.31% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,15,616.01 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Laurus Labs

  • Laurus Labs has set a fresh 52-week high for its second straight session, touching Rs 2,207.00.
  • The stock last traded at Rs 2,174.00, down 0.50% from the previous close of Rs 2,184.95.
  • P/E of 107.97 is 242.44% above the same-industry median of 31.53.
  • ROE of 18.31% and ROCE of 18.20% are above the benchmark medians of 11.22% and 13.10%.
  • Market cap of Rs 1,15,616.01 crore is larger than four of the five peers compared.

About Laurus Labs

Laurus Labs Ltd. trades on NSE under the symbol LAURUSLABS and belongs to the Healthcare sector, in the Pharmaceuticals & Drugs industry. For a reader following the streak, this classification matters because the sector and peer figures above are drawn from that same industry group of 198 companies.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).

Frequently Asked Questions

How many sessions has Laurus Labs set a fresh 52-week high?

Ans. Laurus Labs has set a fresh 52-week high for its second straight session, the first on 28 October 2026 and the second on 29 October 2026, when the stock touched Rs 2,207.00. That is the Laurus Labs 52 Week High Streak so far.

What is the Laurus Labs share price today?

Ans. As of 29 October 2026 at 12:37 PM IST, Laurus Labs last traded at Rs 2,174.00, down Rs 10.95 or 0.50% from the previous close of Rs 2,184.95. The day high and the 52-week high both stand at Rs 2,207.00.

What is the cumulative change across the Laurus Labs streak?

Ans. According to latest Univest data, the cumulative change across the streak is 1.60%. The stock is down 0.50% on the day, so the cumulative figure and today's move are separate facts, and neither one establishes a company-specific catalyst.

Is a company-specific catalyst confirmed for the repeated highs?

Ans. According to Univest data, the price pattern is confirmed, but no company-specific catalyst is established. The stock set a fresh 52-week high on two straight sessions, and the figures describe what the price did without explaining why it moved.

What is the market cap of Laurus Labs?

Ans. The Laurus Labs market cap is Rs 1,15,616.01 crore according to latest Univest data. That compares with a benchmark median of Rs 711.90 crore across the 198 companies in the same Pharmaceuticals & Drugs industry group.

What are the P/E and P/B ratios of Laurus Labs?

Ans. Laurus Labs has a P/E ratio of 107.97 and a P/B ratio of 20.94. The same-industry median P/E is 31.53 and the median P/B is 2.74, so both multiples sit well above the benchmark medians after the streak.

What are the ROE and ROCE of Laurus Labs?

Ans. Laurus Labs reports an ROE of 18.31% and an ROCE of 18.20%. Both are above the same-industry medians of 11.22% and 13.10%, which means the company is ahead of the typical company in its industry group on these two measures.

What are the EPS, book value and dividend yield of Laurus Labs?

Ans. EPS is Rs 20.24, book value per share is Rs 104.37 and dividend yield is 0.09%. Dividend yield is a historical figure relative to the current price and does not promise any future payout, so it works as background context.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can follow the Laurus Labs 52 Week High Streak on Univest, along with the live share price, P/E ratio, P/B ratio, ROE, ROCE, EPS, book value, dividend yield and 52-week levels. Univest also places each ratio beside the same-industry benchmark, so the next session can be read against the figures in this article.



Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply